Publications by authors named "L Cabel"

Claim this Profile
P
PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort.
F Cherifi, L Cabel, C Bousrih, E Volant, F Dalenc

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgery.
Capucine Barjot, Thomas Gaillard, Romain-David Seban, Lauren Darrigues, Delphine Loirat, Luc Cabel

Eur J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals.
Alexandre De Moura, Orane Gleizes, Luc Cabel, Anne Bethune-Volters, Audrey Bellesoeur

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer.
L Cabel, F Berger, T Bachelot, B Pistilli, F Dalenc

Ann Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast Cancer.
Assile El Fakih, Pierre Loap, Luc Cabel, Sofiane Allali, Kim Cao

Am J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis